Cargando…

Focal neuroendocrine carcinoma mixed with adenocarcinoma of the gallbladder with aggressive lymph node metastasis in a patient who did not meet the mixed neuroendocrine–non-neuroendocrine neoplasm criteria

A 70-year-old Japanese woman who was treated for interstitial pneumonia (IP) with steroid therapy developed cholecystitis. A serial computed-tomography (CT) imaging showed irregular thickness of the fundus wall of the gallbladder and two rapidly enlarged lymph nodes (LNs): number (no.) 12 and no. 8a...

Descripción completa

Detalles Bibliográficos
Autores principales: Kadota, Yoshie, Funakoshi, Shinsuke, Hirose, Shigemichi, Shiomi, Eisuke, Odaira, Masanori, Yagishita, Haruka, Kobayashi, Yosuke, Toriumi, Fumiki, Tamai, Seiichi, Endo, Takashi, Harada, Hirohisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Singapore 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8858271/
https://www.ncbi.nlm.nih.gov/pubmed/34767241
http://dx.doi.org/10.1007/s12328-021-01547-8
_version_ 1784654214917521408
author Kadota, Yoshie
Funakoshi, Shinsuke
Hirose, Shigemichi
Shiomi, Eisuke
Odaira, Masanori
Yagishita, Haruka
Kobayashi, Yosuke
Toriumi, Fumiki
Tamai, Seiichi
Endo, Takashi
Harada, Hirohisa
author_facet Kadota, Yoshie
Funakoshi, Shinsuke
Hirose, Shigemichi
Shiomi, Eisuke
Odaira, Masanori
Yagishita, Haruka
Kobayashi, Yosuke
Toriumi, Fumiki
Tamai, Seiichi
Endo, Takashi
Harada, Hirohisa
author_sort Kadota, Yoshie
collection PubMed
description A 70-year-old Japanese woman who was treated for interstitial pneumonia (IP) with steroid therapy developed cholecystitis. A serial computed-tomography (CT) imaging showed irregular thickness of the fundus wall of the gallbladder and two rapidly enlarged lymph nodes (LNs): number (no.) 12 and no. 8a. Positron-emission tomography-computed tomography (PET-CT) scan showed an abnormal uptake at the site of the gallbladder tumor and those LNs. We subsequently performed open radical cholecystectomy and LN dissection of the no. 12 and 8a LNs, following complete remission of IP. The histology showed gallbladder adenocarcinoma, with a single focus of neuroendocrine carcinoma (NEC) component of less than 30%; Ki-67 index > 80%, synaptophysin (Syn) (+), chromogranin A (CgA) (+), and clusters of differentiation (CD) 56 (+) (T2bN1M0, Stage IIIB). LN no. 8a was diffusely metastatic with NEC components. LN no. 12c, which was adjacent to the cystic duct, revealed necrosis without apparent tumor cells, but was highly suspicious for tumor necrosis. The final diagnosis was adenocarcinoma of the gallbladder with focal NEC (< 30%), which did not meet the criteria for mixed neuroendocrine–non-neuroendocrine neoplasm (MiNEN). Postoperatively, she completed 4 cycles of adjuvant chemotherapy for NEC (Cisplatin plus Etoposide), and no recurrence was observed after 12 months. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s12328-021-01547-8.
format Online
Article
Text
id pubmed-8858271
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer Singapore
record_format MEDLINE/PubMed
spelling pubmed-88582712022-02-23 Focal neuroendocrine carcinoma mixed with adenocarcinoma of the gallbladder with aggressive lymph node metastasis in a patient who did not meet the mixed neuroendocrine–non-neuroendocrine neoplasm criteria Kadota, Yoshie Funakoshi, Shinsuke Hirose, Shigemichi Shiomi, Eisuke Odaira, Masanori Yagishita, Haruka Kobayashi, Yosuke Toriumi, Fumiki Tamai, Seiichi Endo, Takashi Harada, Hirohisa Clin J Gastroenterol Case Report A 70-year-old Japanese woman who was treated for interstitial pneumonia (IP) with steroid therapy developed cholecystitis. A serial computed-tomography (CT) imaging showed irregular thickness of the fundus wall of the gallbladder and two rapidly enlarged lymph nodes (LNs): number (no.) 12 and no. 8a. Positron-emission tomography-computed tomography (PET-CT) scan showed an abnormal uptake at the site of the gallbladder tumor and those LNs. We subsequently performed open radical cholecystectomy and LN dissection of the no. 12 and 8a LNs, following complete remission of IP. The histology showed gallbladder adenocarcinoma, with a single focus of neuroendocrine carcinoma (NEC) component of less than 30%; Ki-67 index > 80%, synaptophysin (Syn) (+), chromogranin A (CgA) (+), and clusters of differentiation (CD) 56 (+) (T2bN1M0, Stage IIIB). LN no. 8a was diffusely metastatic with NEC components. LN no. 12c, which was adjacent to the cystic duct, revealed necrosis without apparent tumor cells, but was highly suspicious for tumor necrosis. The final diagnosis was adenocarcinoma of the gallbladder with focal NEC (< 30%), which did not meet the criteria for mixed neuroendocrine–non-neuroendocrine neoplasm (MiNEN). Postoperatively, she completed 4 cycles of adjuvant chemotherapy for NEC (Cisplatin plus Etoposide), and no recurrence was observed after 12 months. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s12328-021-01547-8. Springer Singapore 2021-11-12 2022 /pmc/articles/PMC8858271/ /pubmed/34767241 http://dx.doi.org/10.1007/s12328-021-01547-8 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Case Report
Kadota, Yoshie
Funakoshi, Shinsuke
Hirose, Shigemichi
Shiomi, Eisuke
Odaira, Masanori
Yagishita, Haruka
Kobayashi, Yosuke
Toriumi, Fumiki
Tamai, Seiichi
Endo, Takashi
Harada, Hirohisa
Focal neuroendocrine carcinoma mixed with adenocarcinoma of the gallbladder with aggressive lymph node metastasis in a patient who did not meet the mixed neuroendocrine–non-neuroendocrine neoplasm criteria
title Focal neuroendocrine carcinoma mixed with adenocarcinoma of the gallbladder with aggressive lymph node metastasis in a patient who did not meet the mixed neuroendocrine–non-neuroendocrine neoplasm criteria
title_full Focal neuroendocrine carcinoma mixed with adenocarcinoma of the gallbladder with aggressive lymph node metastasis in a patient who did not meet the mixed neuroendocrine–non-neuroendocrine neoplasm criteria
title_fullStr Focal neuroendocrine carcinoma mixed with adenocarcinoma of the gallbladder with aggressive lymph node metastasis in a patient who did not meet the mixed neuroendocrine–non-neuroendocrine neoplasm criteria
title_full_unstemmed Focal neuroendocrine carcinoma mixed with adenocarcinoma of the gallbladder with aggressive lymph node metastasis in a patient who did not meet the mixed neuroendocrine–non-neuroendocrine neoplasm criteria
title_short Focal neuroendocrine carcinoma mixed with adenocarcinoma of the gallbladder with aggressive lymph node metastasis in a patient who did not meet the mixed neuroendocrine–non-neuroendocrine neoplasm criteria
title_sort focal neuroendocrine carcinoma mixed with adenocarcinoma of the gallbladder with aggressive lymph node metastasis in a patient who did not meet the mixed neuroendocrine–non-neuroendocrine neoplasm criteria
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8858271/
https://www.ncbi.nlm.nih.gov/pubmed/34767241
http://dx.doi.org/10.1007/s12328-021-01547-8
work_keys_str_mv AT kadotayoshie focalneuroendocrinecarcinomamixedwithadenocarcinomaofthegallbladderwithaggressivelymphnodemetastasisinapatientwhodidnotmeetthemixedneuroendocrinenonneuroendocrineneoplasmcriteria
AT funakoshishinsuke focalneuroendocrinecarcinomamixedwithadenocarcinomaofthegallbladderwithaggressivelymphnodemetastasisinapatientwhodidnotmeetthemixedneuroendocrinenonneuroendocrineneoplasmcriteria
AT hiroseshigemichi focalneuroendocrinecarcinomamixedwithadenocarcinomaofthegallbladderwithaggressivelymphnodemetastasisinapatientwhodidnotmeetthemixedneuroendocrinenonneuroendocrineneoplasmcriteria
AT shiomieisuke focalneuroendocrinecarcinomamixedwithadenocarcinomaofthegallbladderwithaggressivelymphnodemetastasisinapatientwhodidnotmeetthemixedneuroendocrinenonneuroendocrineneoplasmcriteria
AT odairamasanori focalneuroendocrinecarcinomamixedwithadenocarcinomaofthegallbladderwithaggressivelymphnodemetastasisinapatientwhodidnotmeetthemixedneuroendocrinenonneuroendocrineneoplasmcriteria
AT yagishitaharuka focalneuroendocrinecarcinomamixedwithadenocarcinomaofthegallbladderwithaggressivelymphnodemetastasisinapatientwhodidnotmeetthemixedneuroendocrinenonneuroendocrineneoplasmcriteria
AT kobayashiyosuke focalneuroendocrinecarcinomamixedwithadenocarcinomaofthegallbladderwithaggressivelymphnodemetastasisinapatientwhodidnotmeetthemixedneuroendocrinenonneuroendocrineneoplasmcriteria
AT toriumifumiki focalneuroendocrinecarcinomamixedwithadenocarcinomaofthegallbladderwithaggressivelymphnodemetastasisinapatientwhodidnotmeetthemixedneuroendocrinenonneuroendocrineneoplasmcriteria
AT tamaiseiichi focalneuroendocrinecarcinomamixedwithadenocarcinomaofthegallbladderwithaggressivelymphnodemetastasisinapatientwhodidnotmeetthemixedneuroendocrinenonneuroendocrineneoplasmcriteria
AT endotakashi focalneuroendocrinecarcinomamixedwithadenocarcinomaofthegallbladderwithaggressivelymphnodemetastasisinapatientwhodidnotmeetthemixedneuroendocrinenonneuroendocrineneoplasmcriteria
AT haradahirohisa focalneuroendocrinecarcinomamixedwithadenocarcinomaofthegallbladderwithaggressivelymphnodemetastasisinapatientwhodidnotmeetthemixedneuroendocrinenonneuroendocrineneoplasmcriteria